Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable?
Saved in:
| Title: | Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable? |
|---|---|
| Authors: | Sutton TL; OHSU Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, Oregon, USA., Billingsley KG; Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA., Johnson AJ; OHSU Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, Oregon, USA., Corless CL; OHSU Department of Pathology, Knight Cancer Institute, Portland, Oregon, USA., Blanke CD; OHSU Department of Medicine, Division of Hematology and Oncology, Knight Cancer Institute, Portland, Oregon, USA., Heinrich MC; OHSU Department of Medicine, Division of Hematology and Oncology, Knight Cancer Institute, Portland, Oregon, USA., Mayo SC; OHSU Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, Oregon, USA. |
| Source: | Journal of surgical oncology [J Surg Oncol] 2024 Jul; Vol. 130 (1), pp. 40-46. Date of Electronic Publication: 2024 Jun 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-9098 |
|---|---|
| DOI: | 10.1002/jso.27654 |
